EASEU
LIVE

Serial Number

79422812

Owner

curetec GmbH

Attorney

Sarah M. Robertson

Filing Date

Jan 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EASEU Trademark

Serial Number: 79422812

EASEU is a trademark filed by curetec GmbH on January 20, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

curetec GmbH

Bismarckstr. 20

Entity Type: 99

Trademark Details

Filing Date

January 20, 2025

Registration Date

Not Registered

Goods & Services

Downloadable and/or recorded mobile apps for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues; downloadable apps for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues; downloadable and/or recorded software for mobile devices, in particular for tablets, laptops and mobile phones for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues; software and mobile phones; downloadable and/or recorded software for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues; downloadable software for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues; downloadable and/or recorded software for receiving, storing, analysing and visualising data, processing, analysing and visualising data; downloadable and/or recorded software for controlling electronic and electromagnetic devices in the nature of wearable neuromodulation and vibration devices; downloadable and/or recorded software for cloud computing services for cognitive therapy activities and the control and management of wearable neuromodulation and vibration devices for the treatment of neurological issues

Medical devices and instruments, namely, wearable neuromodulation and vibration device for the treatment of neurological issues; medical therapy devices, namely, wearable neuromodulation and vibration device for the treatment of neurological issues; devices for the treatment of pain, namely, wearable neuromodulation and vibration device for the treatment of neurological issues and to ease pain; electronic muscle stimulators for medical purposes; devices for vibration treatment, namely, wearable neuromodulation and vibration device for the treatment of neurological issues; electronic nerve stimulators for medical purposes; neurological instruments and devices for vibro-tactile stimulation for the diagnosis of neurological diseases; neurological instruments and devices for vibro-tactile stimulation for the treatment and monitoring of nervous system disorders, mental and behavioural disorders and problems associated with difficulties in coping with life; medical devices for direct and indirect modulation and stimulation of nerve cells; external nerve stimulators and vibro-tactile nerve stimulators for the diagnosis and treatment of neurological diseases

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 17, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 17, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 17, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2026 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 16, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 1, 2025 REPR